SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Soleno Therapeutics Q1 EPS $(0.130) Up From $(0.220) YoY

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.130) per share. This is a 40.91 percent increase over losses of $(0.220) per share from the same period last year.

Benzinga · 05/12/2020 20:01

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.130) per share. This is a 40.91 percent increase over losses of $(0.220) per share from the same period last year.